Skip to main content

Community Series in Translational Insights into Mechanisms and Therapy of Organ Dysfunction in Sepsis and Trauma, volume III

129kviews
Editorial11 July 2024
Editorial: Community series in translational insights into mechanisms and therapy of organ dysfunction in sepsis and trauma - volume III

Translational research on trauma, sepsis, and multiple organ damage is continuously evolving,

fostering advancements in the development of diagnostics and therapeutics, and improving

our understanding of the complex pathophysiological mechanisms underlying these life-threatening

conditions. The contributors of this special issue explore the different aspects of

the pathophysiology of trauma and critical illness. With different approaches, these studies

describe novel potential diagnostic markers, innovative therapeutic interventions, and

elucidate the complex mechanisms underlying immune responses and organ damage in

patients with trauma, sepsis and/or multiple organ failure.

Life-threatening organ dysfunction and failure in trauma and critically ill patients stem from a

dysregulated host response to infection and inflammation. Despite advancements in

understanding the key signaling pathways involved, translating this knowledge into organprotective

therapies remains challenging. Current treatments primarily rely on infection

control, antibiotics, supportive care, and early goal-directed therapy.

Trauma and sepsis-induced organ dysfunction are driven by excessive systemic inflammation,

secondary to tissue damage and ischemia-reperfusion injury. The endothelial glycocalyx is a

critical early site involved in triggering a pro-inflammatory response. Alterations in its

structure lead to the release of degradation products and damage-associated molecular

patterns (DAMPs) that, along with pathogen-associated molecular patterns (PAMPs), amplify

systemic inflammation and, hence, contribute to organ dysfunction including acute kidney

injury, respiratory failure, and cardiomyopathy.

Three major fields of research have been covered by the authors. First, in terms of sepsis

diagnosis and treatment, Dennhardt et al. investigate the clinical significance of circulating

cell-free DNA (cfDNA) levels in sepsis patients as predictors of both mortality and sepsisassociated

acute kidney injury, suggesting elevated cfDNA levels as a potential enhancer of

risk assessment in sepsis (1). Similarly, Qiang et al. explore the therapeutic potential of

progesterone in sepsis, presenting promising results in septic mice and patients by inhibiting

procathepsin-L-mediated inflammation (2). Guggemos et al. investigate the impact of specific

polymorphisms of the ATP-sensitive P2X7 receptor on sepsis susceptibility and prognosis,

revealing their potential role as genetic markers (3). Wakeley et al. examine the role of

Herpes virus entry mediator in neonatal sepsis response, highlighting its importance in

vascular and hemodynamic resilience (4), while Kasper et al. study the effects of

hemadsorption therapy on endothelial barrier dysfunction in sepsis in vitro, indicating its

potential transient clinical improvement (5).

Second, with a focus on trauma, injury, and organ damage, Horner et al. explore the immune

suppressive role of DAMPs in sterile traumatic injury, proposing potential therapeutic

strategies to mitigate immune suppression in their review (6). Wolfschmitt et al. investigate

the impact of hyperoxemia on the metabolism of circulating immune cells during intensive

care, focusing on granulocytes in models of acute subdural hematoma and hemorrhagic shock

(7). Groven et al. explore the association between circulating miRNA expression in

extracellular vesicles (EVs) as biomarkers for specific injuries following multiple trauma and

surgical invasiveness (8). Meng et al. investigate how aging influences liver inflammation and

damage after trauma, highlighting dysregulated immune responses (9), while Zhou et al.

examine the exacerbation of lung damage after trauma in aged mice, focusing on the role of

NF-κB and inflammasomes (10). Neu et al. explore the cardiovascular impairment in a

murine model of hemolytic-uremic syndrome induced by Shiga toxin, a model which

replicates the extrarenal manifestations observed in HUS patients (11). Fachet et al. propose a

feature-based risk assessment system for predicting hyperinflammatory patterns and

infectious outcomes in polytrauma patients using predictive machine learning modeling (12).

The third part of this article collection addresses therapeutic interventions and drug

repurposing. Verra et al. investigate the effects of baricitinib, a JAK1/JAK2 inhibitor, on

sepsis-induced cardiac dysfunction and multiple-organ failure, suggesting its potential for

trauma-associated sepsis (13). Hof et al. study the effects of carbachol on gastric and oral

microcirculation during hemorrhagic shock in dogs, highlighting its potential therapeutic use

in improving tissue oxygenation (14). Yamaga et al. discuss potential therapeutic strategies

targeting DAMPs to alleviate radiation-induced injury, focusing on the mechanisms of DAMP

release and their detrimental effects on the immune system (15). To advance our

understanding of critical illness, Li et al. identify key genes and pathways associated with

DNA damage responses, inflammation, and cellular senescence in elderly patients with acute

respiratory distress syndrome, offering insights into potential diagnostic biomarkers and

therapeutic targets (16). Murao et al. utilize single-cell RNA sequencing to investigate

immune cell responses in sepsis, providing insights into distinct immune cell subsets and their

roles in inflammation and tissue repair, thus enhancing our understanding of the

pathophysiology of sepsis (17). Wang et al. conducted the LiBOD study to assess the

potential of serum-derived EVs as biomarkers for decision-making in polytrauma cases,

suggesting specific EVs as valuable biomarkers for assessing and monitoring the severity of

polytrauma and associated organ damage (18).

These studies collectively contribute to a better understanding of diagnostic markers,

therapeutic interventions, immune responses, and the mechanisms underlying organ injury

and dysfunction in trauma, sepsis, and related conditions, offering potential avenues for

improving care and outcomes of patients with critical illness.

As we review the research presented in this issue, it is clear how scientific research

significantly shapes the field of trauma and critical care medicine, addressing the issue of

improving patient outcomes, moving towards precision medicine in intensive care.

We conclude this special issue with deep gratitude to the researchers, clinicians, and patients

whose dedication has made this work possible. We hope the insights from these studies will

be interesting and educational to our readers and help developing this area of research on a

challenging condition.

1,718 views

1 citations

ORIGINAL RESEARCH
13 May 2024
Cell-free DNA in patients with sepsis: long term trajectory and association with 28-day mortality and sepsis-associated acute kidney injury
Sophie Dennhardt, 4 more and Sina M. Coldewey

5,470 views

19 citations

ORIGINAL RESEARCH
15 March 2024
ARDS and aging: TYMS emerges as a promising biomarker and therapeutic target
Gang Li, 3 more and Pengxiang Guo

6,617 views

19 citations

ORIGINAL RESEARCH
19 March 2024
Local carbachol application induces oral microvascular recruitment and improves gastric tissue oxygenation during hemorrhagic shock in dogs
Stefan Hof, 8 more and Christian Vollmer

2,945 views

8 citations

ORIGINAL RESEARCH
12 December 2023
Utilizing predictive machine-learning modelling unveils feature-based risk assessment system for hyperinflammatory patterns and infectious outcomes in polytrauma
Melanie Fachet, 4 more and Borna Relja

4,139 views

15 citations

ORIGINAL RESEARCH
23 October 2023
Circulating miRNA expression in extracellular vesicles is associated with specific injuries after multiple trauma and surgical invasiveness
Rald Victor Maria Groven, 7 more and Martijn van Griensven

4,376 views

14 citations

ORIGINAL RESEARCH
15 November 2023
Liquid Biopsy in Organ Damage: small extracellular vesicle chip-based assessment of polytrauma
Bingduo Wang, 20 more and Miroslaw T. Kornek

5,502 views

7 citations

ORIGINAL RESEARCH
9 January 2024
13C-Metabolic flux analysis detected a hyperoxemia-induced reduction of tricarboxylic acid cycle metabolism in granulocytes during two models of porcine acute subdural hematoma and hemorrhagic shock
Eva-Maria Wolfschmitt, 16 more and Fabian Zink

3,364 views

1 citations

The immune suppressive properties of damage associated molecular patterns in the setting of sterile traumatic injury
Associated with the development of hospital-acquired infections, major traumatic injury results in an immediate and persistent state of systemic immunosuppression, yet the underlying mechanisms are poorly understood.Detected in the circulation in the minutes, days and weeks following injury, damage associated molecular patterns (DAMPs) are a heterogeneous collection of proteins, lipids and DNA renowned for initiating the systemic inflammatory response syndrome. Suggesting additional immunomodulatory roles in the post-trauma immune response, data are emerging implicating DAMPs as potential mediators of post-trauma immune suppression.Discussing the results of in vitro, in vivo and ex vivo studies, the purpose of this review is to summarise the emerging immune tolerising properties of cytosolic, nuclear and mitochondrial-derived DAMPs. Direct inhibition of neutrophil antimicrobial activities, the induction of endotoxin tolerance in monocytes and macrophages, and the recruitment, activation and expansion of myeloid derived suppressor cells and regulatory T cells are examples of some of the immune suppressive properties assigned to DAMPs so far. Crucially, with studies identifying the molecular mechanisms by which DAMPs promote immune suppression, therapeutic strategies that prevent and/or reverse DAMP-induced immunosuppression have been proposed. Approaches currently under consideration include the use of synthetic polymers, or the delivery of plasma proteins, to scavenge circulating DAMPs, or to treat critically-injured patients with antagonists of DAMP receptors. However, as DAMPs share signalling pathways with pathogen associated molecular patterns, and pro-inflammatory responses are essential for tissue regeneration, these approaches need to be carefully considered in order to ensure that modulating DAMP levels and/or their interaction with immune cells does not negatively impact upon anti-microbial defence and the physiological responses of tissue repair and wound healing.

7,636 views

34 citations